Primary operable, non-metastatic invasive carcinoma of the breast, confirmed histologically by core biopsy.
Diagnosis of histologically confirmed invasive primary rectal carcinoma
Patients must have stage I to III histologically confirmed invasive carcinoma of the breast; a minimum tumor size of at least 1.5 cm determined by physical exam or imaging (whichever is larger) is required
Histologically-proven, invasive primary carcinoma of the cervix
Patients with histologically confirmed carcinoma of the female breast with any or unknown hormone receptors (HRs)/HER2 status
Histologically confirmed infiltrating carcinoma of the breast (stage I-III)
Histologically or cytologically confirmed carcinoma of the breast
Patients must have HER2-positive stage II or III histologically confirmed invasive carcinoma of the breast; a minimum tumor size of 2 cm determined by physical exam or imaging (whichever is larger) is required
Histologically confirmed unilateral or bilateral primary invasive carcinoma of the breast.
Histologically or cytologically confirmed carcinoma of the breast
Non-metastatic operable primary invasive HER2-positive carcinoma of the breast that is histologically confirmed, and adequately excised
Histologically or cytologically confirmed invasive breast carcinoma with local recurrence or radiological evidence of metastatic disease.
Patients must have a histologically confirmed diagnosis of hormone receptor positive, HER2 negative invasive breast carcinoma
Non-metastatic histologically confirmed primary invasive breast carcinoma that was operable
Diagnosis of LGS carcinoma of the ovary, fallopian tube or primary peritoneum (invasive micropapillary serous carcinoma or invasive grade 1 serous carcinoma), confirmed histologically and verified by central pathology review.
Histologically confirmed invasive breast carcinoma
Histologically or cytologically confirmed invasive breast carcinoma at local institution
Have histologically confirmed breast or ovarian carcinoma
Histologically or cytologically confirmed invasive carcinoma of the breast
Histologically or cytologically confirmed invasive breast carcinoma
Histologically or cytologically confirmed breast carcinoma
Women histologically diagnosed with carcinoma of the breast
Histologically confirmed serous carcinoma or endometrioid type of endometrial carcinoma (histological documentation of recurrence is not required);
Histologically confirmed carcinoma of the breast
Non-metastatic histologically confirmed primary invasive breast carcinoma
Patients must be women with histologically confirmed primary invasive carcinoma of the breast (stage I, II, or III) with no evidence of metastatic disease (M0) or with histologically confirmed ductal carcinoma in situ (DCIS); if patient has undergone breast cancer surgery, she must have recovered from all side-effects of surgery
Breast carcinoma:
Participants must have histologically or cytologically confirmed invasive or in-situ carcinoma of the breast